• Tiamulin (Thiamutilin): Translational Leverage from Ribosome

  2026-04-20

  This thought-leadership article delivers a mechanistic and strategic roadmap for translational researchers exploring Tiamulin (Thiamutilin). By integrating cutting-edge ribosomal structural biology with translational workflows, the piece highlights APExBIO’s Tiamulin as a dual-action tool for both veterinary infection control and emerging anti-inflammatory applications. It benchmarks protocol design, resistance management, and domain-bridging opportunities, empowering the next era of pleuromutilin antibiotic research.

• Fluorinated CXCR4 Inhibitor A1 vs. Plerixafor in Colorectal

  2026-04-19

  The reference study by Khorramdelazad et al. introduces A1, a novel fluorinated CXCR4 inhibitor, and demonstrates its superior efficacy over Plerixafor (AMD3100) in colorectal cancer models. Through integrated computational, cellular, and animal approaches, A1 exhibited enhanced tumor inhibition and immune modulation, highlighting its potential to reshape targeted therapy development.

• rhBNP, Ferroptosis, and Selenium Recycling in Renal IR Injur

  2026-04-18

  This study uncovers a novel mechanism by which recombinant human brain natriuretic peptide (rhBNP) protects against renal ischemia-reperfusion injury, specifically through upregulation of selenocysteine lyase (SCLY) and promotion of selenium recycling, leading to inhibition of ferroptosis. The findings highlight SCLY as a potential therapeutic target for acute kidney injury and provide a mechanistic framework for future research on renal protection strategies.

• Geneticin (G-418 Sulfate): Precision Selection and Antiviral

  2026-04-17

  Discover how Geneticin (G-418 Sulfate) empowers advanced genetic engineering and antiviral research. This article explores the molecular mechanism, unique protocol parameters, and practical insights that set it apart in biotechnology workflows.

• Dopaminergic Modulation of Bladder Function in Parkinson’s D

  2026-04-16

  This study investigates how rotigotine, a D1/D2-like dopaminergic agonist, influences lower urinary tract function in a rat model of Parkinson’s disease. The findings reveal distinct effects of administration route on bladder dynamics, offering new mechanistic insights for non-motor symptom management in PD.

• FLOT1-FOSL2-EphA2 Axis Regulates Microglial Polarization in

  2026-04-15

  This study uncovers a mechanistic link between FLOT1, FOSL2, and EphA2 in driving microglial polarization and neuroinflammation in Alzheimer's disease. By dissecting how this axis modulates pro-inflammatory signaling, the findings highlight new targets for regulating neurotoxicity and cognitive decline in preclinical AD models.

• SP2509: Potent Lysine-Specific Demethylase 1 Antagonist for

  2026-04-14

  SP2509 is a highly selective Lysine-specific demethylase 1 antagonist with nanomolar potency and proven efficacy in acute myeloid leukemia models. It disrupts LSD1-CoREST interactions, induces apoptosis, and enhances differentiation in AML cells, offering robust utility for cancer epigenetics research.

• Anisomycin: Advancing JNK Agonist Strategies in Translationa

  2026-04-13

  This thought-leadership article explores the mechanistic depth and translational potential of Anisomycin as a potent JNK agonist, integrating evidence from recent neuroscience and oncology research. It offers actionable guidance for researchers aiming to leverage JNK pathway activation in apoptosis and synaptic plasticity, contextualizes APExBIO’s Anisomycin in the competitive landscape, and outlines strategic avenues for bridging mechanistic insights to clinical innovations.

• Phosphatase Inhibitor Cocktail 3 (100X in DMSO): Lab-Proven

  2026-04-13

  This article delivers scenario-driven, evidence-based guidance for using Phosphatase Inhibitor Cocktail 3 (100X in DMSO) (SKU K1014) to overcome common challenges in phosphoprotein workflows. Learn how this serine/threonine phosphatase inhibitor blend ensures reliable protein phosphorylation preservation, supports sensitive phosphoprotein analysis, and enhances reproducibility across cell-based assays.

• mRNA-LNP Programming of CAR Macrophages for Solid Tumor Immu

  2026-04-12

  Gu et al. (2025) introduce an intraperitoneal mRNA lipid nanoparticle (LNP) system to program tailored chimeric antigen receptor macrophages (CAR-Ms) in situ for combating peritoneal metastasis in solid tumors. Their systematic evaluation of CAR formats reveals potent immune activation and synergy with PD-1/L1 therapy, providing vital mechanistic insights for next-generation immunotherapy.

• 3-Bromopyruvate and Cetuximab Synergy: Ferroptosis in CRC Re

  2026-04-12

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab overcomes drug resistance in colorectal cancer cells by activating autophagy-dependent ferroptosis and apoptosis. The findings highlight new mechanistic pathways and therapeutic avenues to address cetuximab resistance in clinical oncology.

• KX2-391 Dihydrochloride: Dual-Action Protocols for Oncology

  2026-04-11

  KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) empowers researchers with dual inhibition of Src kinase and tubulin polymerization, opening new avenues in cancer and HBV research. Explore optimized experimental workflows, troubleshooting insights, and actionable tips for maximizing its translational impact.

• Jasplakinolide: Actin Polymerization Inducer for Advanced Cy

  2026-04-11

  Jasplakinolide stands out as a high-affinity, membrane-permeable actin polymerization inducer that empowers researchers to probe cytoskeletal dynamics with reproducibility and precision. Explore protocol enhancements, troubleshooting strategies, and cross-domain insights that elevate its use in cutting-edge cell biology and antifungal studies.

• 2-((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)acetic

  2026-04-10

  2-((1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl)amino)acetic acid (CAS 5704-04-1) is a water-soluble organic compound used as a biochemical and molecular biology buffer component. It enables researchers to maintain pH stability in assay environments but should not be used in diagnostic or medical workflows. Best suited for research buffer preparation, with attention to storage and concentration limits to ensure reagent integrity.

• Cell Counting Kit-8 (CCK-8) Plus: Scenario-Driven Lab Opt...

  2026-04-10

  This article unpacks real-world laboratory challenges in cell viability, proliferation, and cytotoxicity assays and offers evidence-based strategies using the Cell Counting Kit-8 (CCK-8) Plus (SKU K2268). Senior scientists will find scenario-guided insights, grounded in quantitative data and recent literature, to optimize WST-8 based cell viability and drug screening workflows.

586 records 13/40 page Previous Next First page 上5页 1112131415 下5页 Last page